Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting
Blood Adv
.
2021 Nov 9;5(21):4500-4503.
doi: 10.1182/bloodadvances.2021005637.
Authors
Maria A V Marzolini
1
2
,
Varun Mehra
3
,
Kirsty J Thomson
2
,
Eleni Tholouli
4
,
Adrian J C Bloor
5
,
Anne Parker
6
,
Richard Lovell
7
,
Kim Orchard
8
,
Amy Publicover
9
,
Emma Nicholson
10
,
John A Snowden
11
,
Jennifer Byrne
12
,
Anjum Khan
13
,
Maria H Gilleece
13
,
Gerardo Errico
12
,
Sara Lozano
10
,
Erin Hurst
9
,
Nick Duncan
7
,
Jennifer Pirrie
6
,
Philip Crea
4
,
Ben Carpenter
2
,
Antonio Pagliuca
3
,
Karl S Peggs
1
2
Affiliations
1
Department of Haematology, UCL Cancer Institute, University College London, London, United Kingdom.
2
Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
3
Department of Haematology, Kings College Hospital, London, United Kingdom.
4
Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom.
5
Department of Haematology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
6
Department of Haematology, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
7
Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
8
Department of Haematology, University Hospital Southampton, Southampton, United Kingdom.
9
Department of Haematology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom.
10
Department of Haematology, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
11
Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
12
Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; and.
13
Department of Haematology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
PMID:
34614515
PMCID:
PMC8579255
DOI:
10.1182/bloodadvances.2021005637
No abstract available
Publication types
Comment
MeSH terms
Acetates
Cytomegalovirus
Cytomegalovirus Infections* / prevention & control
Humans
Quinazolines
T-Lymphocytes*
Substances
Acetates
Quinazolines
letermovir